Article
Global prevalence and phylogeny of hepatitis B virus (HBV) drug and vaccine resistance mutations.
Journal of viral hepatitis - 1 Aug 2021
Mokaya Jolynne, Vasylyeva Tetyana I, Barnes Eleanor, Ansari M Azim, Pybus Oliver G, Matthews Philippa C
Abstract excerpt
Vaccination and anti-viral therapy with nucleos(t)ide analogues (NAs) are key approaches to reducing the morbidity, mortality and transmission of hepatitis B virus (HBV) infection. However, the efficacy of these interventions may be reduced by the emergence of drug resistance-associated mutations (RAMs) and/or vaccine escape mutations (VEMs). We have assimilated data on the global prevalence and distribution of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
